Malta vs Palestine, State of: Hepatitis B surface antigen (HBsAg) prevalence
Malta
0.0%
in 2024
Palestine, State of
0.0%
in 2024
Malta rank
132nd
Palestine, State of rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Malta
- Palestine, State of
How they compare
Malta currently reports 0.0% against 0.0% in Palestine, State of, a difference of 0.0%.
Across all 10 years both countries report, Palestine, State of has been ahead every year.
Malta ranks 132nd and Palestine, State of ranks 132nd of 194 countries.
Palestine, State of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | Palestine, State of |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Malta or Palestine, State of?
- Malta, at 0.0% against 0.0% in Palestine, State of as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Malta and Palestine, State of?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Palestine, State of?
- 10 years are reported by both, from 2015 to 2024.
- How do Malta and Palestine, State of rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Malta ranks 132nd and Palestine, State of ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.